Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

New CRISPR Device Diagnoses COVID in an Hour, Detects Variants

A team of engineers from MIT and Harvard University has developed a COVID diagnostic device with a tiny footprint but huge potential. The tabletop instrument costs around $15 to manufacture and is powered by CRISPR technology. It provides COVID results from spit samples in an hour. In their new study published in Science Advances, the researchers report that the device is incredibly accurate, matching performance levels of the current gold standard, the PCR test. Moreover, the technology can be adapted to identify SARS-CoV-2 variants, making it easy to track the circulation of these mutants without the need for genetic sequencing facilities.